The expanded reimbursement access aims to make the FDA-cleared device more affordable for patients with conditions linked to hypoxia. Key takeaways:
Eligible patients can now access the OxiWear continuous oxygen measuring device through Medicare and participating insurance providers. The FDA-cleared prescription wearable provides continuous blood oxygen measurement and real-time low-oxygen alerts during both motion and rest. OxiWear demonstrate…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.